Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Comment by BurconNutriFanon Apr 21, 2016 10:58pm
75 Views
Post# 24797341

RE:Real News

RE:Real NewsThe only news with pharma will be completion of the trials then a deal. There is no such thing as being half pregnant with a pharma deal so serious investors wait for the total deal or nothing. That is why they call these things a deal not a "50% deal 50% dream". If there was a problem to date the trial would have ended so keep fingers crossed. """""dog toothpaste may be in Q2 or 3 """""""Likely they wont get full $3.6M so the other products like shampoo for humans may not happen in Q4. Again it is science and formulations have ot be tweaked as the science unfolds not as your patience demands. """"""""""""""This is science and products don't march out of vending machines like you keep posting here that you want them to do but you cant accept that so you keep complaining that news is hidden from your eyes."""""""""""""" And all products and programs have to compete with the others for the scarce $ if the full $3.6M doesn't come in 2 weeks.
Bullboard Posts